A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies혈액암이 있는 성인 환자의 SARS-CoV-2 백신 1차 및 2차 접종에 대한 면역 반응의 체계적인 검토 및 메타 분석Review Published on 2022-09-012022-09-11 Journal: International immunopharmacology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] 95% confidence interval 95%CI affected affecting anti-CD20 therapy antibody Antibody detection Antibody Response article booster dose booster doses calculated Cancer patients chronic lymphocytic leukemia CLL Complete conducted coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines develop Diagnosis disease doses evaluate first dose Google Google Scholar healthy subject healthy subjects Hematological malignancies Hematological malignancy higher risk highlight highlighting immune response Immunity immunization Immunocompromised immunogenicity immunosuppressive IMPROVE kinase inhibitors less leukemia lowest Lymphocytic leukemia lymphoma malignancy measure Meta-analysis mRNA mRNA-1273 Myeloma Patient Primary outcome response rate SARS-CoV-2 SARS-CoV-2 vaccine second dose secondary outcome Secondary outcomes seropositive Seropositivity severe coronavirus disease solid tumor solid tumors status subgroup subtype systematic review the disease the vaccine tumors tyrosine tyrosine kinase inhibitor tyrosine kinase inhibitors Vaccine vaccine dose vaccine's immunogenicity Web of Science [DOI] 10.1016/j.intimp.2022.109046 PMC 바로가기 [Article Type] Review
Seropositivity to SARS-CoV-2 in Alberta, Canada in a post-vaccination period (March 2021-July 2021)Article Published on 2022-09-012023-07-09 Journal: Infectious diseases (London, England) [Category] COVID19(2023년), [키워드] anti-receptor binding domain COVID-19 SARS-CoV-2 Seropositivity Serosurveillance [DOI] 10.1080/23744235.2022.2080250
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV: A cross-sectional studyHIV 보균자에서 비활성화된 SARS-CoV-2 백신의 면역원성과 안전성: 단면 연구Article Published on 2022-09-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, [키워드] Analysis antibody Antiretroviral therapy appear ART CD4+ T cell CD4+ T cells CD4+ T-cell chemiluminescence Chinese control group COVID-19 COVID-19 vaccine cross-sectional delta variant Delta variants detect Efficacy and safety enzyme enzyme immunoassay healthy individual Human immunodeficiency virus IgG IgM antibodies IgM antibody immunoassay immunodeficiency immunogenicity inactivated indicated individual Mild multivariable analysis NAb Neutralizing neutralizing antibody Odds ratio PLWH proportion Safe SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2-specific IgG self-limiting seropositive Seropositivity serum IgG serum levels Side effect Side effects significantly higher T cells titers vaccination was used wild-type SARS-CoV-2 with HIV [DOI] 10.1002/jmv.27872 PMC 바로가기 [Article Type] Article
SARS-CoV-2 seroprevalence among healthcare personnel at a large health system in AtlantaArticle Published on 2022-09-012022-11-15 Journal: The American journal of the medical sciences [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] Atlanta clinical care clinician community exposure conducted COVID-19 Cycle threshold value detectable estimate evaluated exposure to Factor female hcp health system healthcare healthcare personnel Healthcare system Healthcare workers hospital IgG IgG antibody Infection majority material offered patient with COVID-19 PCR PCR testing polymerase chain positive result Prevalence provided SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 RNA SARS-CoV-2 seroprevalence Seropositivity Serosurvey System unique [DOI] 10.1016/j.amjms.2022.04.009 PMC 바로가기
The REinfection in COVID-19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workersCOVID-19 위험 평가(RECOVER) 연구의 재감염: 캐나다 의료 종사자 집단의 재감염 및 혈청학 역학Observational Study Published on 2022-09-012022-09-11 Journal: Influenza and Other Respiratory Viruses [Category] COVID19(2023년), SARS, 변종, 임상, 치료기술, [키워드] absence age average Characteristics Cohort conducted COVID-19 Efficacy estimation Follow-up HCWs healthcare healthcare worker IgG immune response incidence rate management median natural immunity natural infection obesity Other pandemic PCR-confirmed Primary infection prospective cohort study prospective studies Reinfection remained SARS-CoV-2 SARS-COV-2 infection serological serology Seropositivity Spike protein the spike protein Uncertainty understanding vaccination variants [DOI] 10.1111/irv.12997 PMC 바로가기 [Article Type] Observational Study
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosisArticle Published on 2022-09-012022-11-15 Journal: Clinical Rheumatology [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI Affect Antibody titer BNT162b2 CCS Clinical characteristics Cohort Comorbidity Corticosteroids COVID-19 difference disease evaluated Fisher exact test healthy control humoral Humoral response Immunosuppression immunosuppressive Immunosuppressive treatment IQR Logistic regression analysis low dose Mann-Whitney methotrexate mRNA vaccination mRNA vaccine MTX Patient patients patients treated Point reduced Regression model risk RTX SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine second dose serological response seropositive Seropositivity serum IgG severe disease course student systemic Systemic sclerosis t-test therapy Treatment untreated patient vaccination Vaccine vaccine-induced antibody [DOI] 10.1007/s10067-022-06219-7 PMC 바로가기
Manufacturer Signal-to-Cutoff Threshold Underestimates Cumulative Incidence of SARS-CoV-2 Infection: Evidence from the Los Angeles Firefighters StudyArticle Published on 2022-09-012022-11-15 Journal: The journal of applied laboratory medicine [Category] SARS, 진단, [키워드] Accuracy Analysis antibody Antibody testing Blood characteristic Cohort COVID-19 cumulative disease firefighter IgG incidence Infection Los Angele Los Angeles negative control negative sample Patient PCR-positive Prevalence reported ROC ROC Curve SARS-CoV-2 SARS-CoV-2-specific antibody sensitivity Sensitivity and specificity serologic analysis seropositive Seropositivity serostatus significantly specificity threshold thresholds USA venipuncture was determined were used [DOI] 10.1093/jalm/jfac034 PMC 바로가기
Serologic Status and SARS-CoV-2 Infection over 6 Months of Follow Up in Healthcare Workers in Chicago: A Cohort StudyArticle Published on 2022-09-012022-11-15 Journal: Infection Control and Hospital Epidemiology [Category] SARS, 진단, [키워드] 95% confidence interval Abbott adjusted analyzed anti-Nucleocapsid IgG antibody status baseline Baseline serology baseline serostatus changes in checked Chicago cohort study coronavirus disease COVID-19 criteria demographics determine Follow-up HCW HCWs healthcare worker identify Infection median moderate Month participant PCR PCR positive polymerase chain positive positive PCR Prospective recruited Reinfection Respiratory Coronavirus risk SARS-CoV-2 SARS-COV-2 infection seroconverted serologic serology serology testing seronegative seronegative participant seropositive Seropositivity setting status virus was used were assessed worker [DOI] 10.1017/ice.2021.367 PMC 바로가기
Immunogenicity of COVID-19 vaccines in patients with diverse health conditions: A comprehensive systematic reviewArticle Published on 2022-09-012023-06-20 Journal: Journal of medical virology [Category] Fulltext, MERS, [키워드] COVID-19 Health status immunogenicity Seropositivity Vaccine [DOI] 10.1002/jmv.27828 PMC 바로가기
Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samplesArticle Published on 2022-08-292022-11-15 Journal: BMJ Open [Category] SARS, 진단, 치료기술, [키워드] 95% CI age age and sex anti-Spike IgG Antibody detection Blood Canada Cohort collected Community COVID-19 COVID-19 vaccine cross-sectional cross-sectional survey current DBS sample Demographic factors Epidemiology Factor Gender Health Immunity impacted incidence rate indicated individuals information outcome pandemic participant Participants Prevalence Public public health remained SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection serology seropositive Seropositivity Sex Sociodemographic submitted the SARS-CoV-2 was performed [DOI] 10.1136/bmjopen-2022-062567 PMC 바로가기